868 related articles for article (PubMed ID: 25952500)
21. CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis.
Morgado JM; Perbellini O; Johnson RC; Teodósio C; Matito A; Álvarez-Twose I; Bonadonna P; Zamò A; Jara-Acevedo M; Mayado A; Garcia-Montero A; Mollejo M; George TI; Zanotti R; Orfao A; Escribano L; Sánchez-Muñoz L
Histopathology; 2013 Dec; 63(6):780-7. PubMed ID: 24111625
[TBL] [Abstract][Full Text] [Related]
22. Anaphylaxis with clonal mast cells in normal looking skin - a new entity?
Bretterklieber A; Beham-Schmid C; Sturm GJ; Berghold A; Brezinschek R; Aberer W; Aberer E
Allergy; 2015 Jul; 70(7):864-72. PubMed ID: 25899109
[TBL] [Abstract][Full Text] [Related]
23. Morphologically occult systemic mastocytosis in bone marrow: clinicopathologic features and an algorithmic approach to diagnosis.
Reichard KK; Chen D; Pardanani A; McClure RF; Howard MT; Kurtin PJ; Wood AJ; Ketterling RP; King RL; He R; Morice WG; Hanson CA
Am J Clin Pathol; 2015 Sep; 144(3):493-502. PubMed ID: 26276780
[TBL] [Abstract][Full Text] [Related]
24. Primary role of multiparametric flow cytometry in the diagnostic work-up of indolent clonal mast cell disorders.
Perbellini O; Zamò A; Colarossi S; Zampieri F; Zoppi F; Bonadonna P; Schena D; Artuso A; Martinelli G; Chilosi M; Pizzolo G; Zanotti R
Cytometry B Clin Cytom; 2011 Nov; 80(6):362-8. PubMed ID: 21656905
[TBL] [Abstract][Full Text] [Related]
25. Detection of phospho-STAT5 in mast cells: a reliable phenotypic marker of systemic mast cell disease that reflects constitutive tyrosine kinase activation.
Zuluaga Toro T; Hsieh FH; Bodo J; Dong HY; Hsi ED
Br J Haematol; 2007 Oct; 139(1):31-40. PubMed ID: 17662084
[TBL] [Abstract][Full Text] [Related]
26. Impact of centralized evaluation of bone marrow histology in systemic mastocytosis.
Jawhar M; Schwaab J; Horny HP; Sotlar K; Naumann N; Fabarius A; Valent P; Cross NC; Hofmann WK; Metzgeroth G; Reiter A
Eur J Clin Invest; 2016 May; 46(5):392-7. PubMed ID: 26914980
[TBL] [Abstract][Full Text] [Related]
27. Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes.
Florian S; Krauth MT; Simonitsch-Klupp I; Sperr WR; Fritsche-Polanz R; Sonneck K; Födinger M; Agis H; Böhm A; Wimazal F; Horny HP; Valent P
Int Arch Allergy Immunol; 2005 Mar; 136(3):273-80. PubMed ID: 15722637
[TBL] [Abstract][Full Text] [Related]
28. [Systemic mastocytosis].
Fain O; Stirnemann J; Eclache V; Barete S; Casassus P; Hermine O; Lorholary O
Presse Med; 2005 May; 34(9):681-7. PubMed ID: 15988348
[TBL] [Abstract][Full Text] [Related]
29. [IgE mediated anaphylaxis in a patient with systemic mastocytosis].
Escande H; Bennani I; Bulai Livideanu C; Uthurriague C; Paul C; Nougué J
Ann Dermatol Venereol; 2013 Oct; 140(10):641-4. PubMed ID: 24090896
[TBL] [Abstract][Full Text] [Related]
30. Expression of CD2 and CD25 on mast cell populations can be seen outside the setting of systemic mastocytosis.
Cherian S; McCullouch V; Miller V; Dougherty K; Fromm JR; Wood BL
Cytometry B Clin Cytom; 2016 Jul; 90(4):387-92. PubMed ID: 26525770
[TBL] [Abstract][Full Text] [Related]
31. Bone marrow tryptase as a possible diagnostic criterion for adult systemic mastocytosis.
Bulai Livideanu C; Apoil PA; Lepage B; Eischen M; Laurent C; Laharrague P; Lamant L; Tournier E; Tavitian S; Pouplard C; Recher C; Laroche M; Mailhol C; Dubreuil P; Hermine O; Blancher A; Paul C
Clin Exp Allergy; 2016 Jan; 46(1):133-41. PubMed ID: 26767494
[TBL] [Abstract][Full Text] [Related]
32. Mastocytosis: classification, diagnosis, and clinical presentation.
Castells MC
Allergy Asthma Proc; 2004; 25(1):33-6. PubMed ID: 15055560
[TBL] [Abstract][Full Text] [Related]
33. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
Hong GU; Park BS; Park JW; Kim SY; Ro JY
Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and subdiagnostic accumulation of mast cells in the bone marrow of patients with anaphylaxis: Monoclonal mast cell activation syndrome.
Sonneck K; Florian S; Müllauer L; Wimazal F; Födinger M; Sperr WR; Valent P
Int Arch Allergy Immunol; 2007; 142(2):158-64. PubMed ID: 17057414
[TBL] [Abstract][Full Text] [Related]
35. Myelomastocytic leukemia: histopathological features, diagnostic criteria and differential diagnosis.
Horny HP; Sotlar K; Reiter A; Valent P
Expert Rev Hematol; 2014 Aug; 7(4):431-7. PubMed ID: 25025369
[TBL] [Abstract][Full Text] [Related]
36. Validation of the REMA score for predicting mast cell clonality and systemic mastocytosis in patients with systemic mast cell activation symptoms.
Alvarez-Twose I; González-de-Olano D; Sánchez-Muñoz L; Matito A; Jara-Acevedo M; Teodosio C; García-Montero A; Morgado JM; Orfao A; Escribano L
Int Arch Allergy Immunol; 2012; 157(3):275-80. PubMed ID: 22042301
[TBL] [Abstract][Full Text] [Related]
37. An Unusual Transition from Cutaneous to Systemic Mastocytosis in a Pediatric Patient.
Patel K; Cuervo-Pardo L; Cresoe S; Cavero-Chavez V
Pediatr Allergy Immunol Pulmonol; 2023 Dec; 36(4):150-152. PubMed ID: 38134319
[No Abstract] [Full Text] [Related]
38. Mastocytosis: a comprehensive insight.
VAN Gysel D; DE Maeseneer H; Oranje AP
G Ital Dermatol Venereol; 2016 Aug; 151(4):385-96. PubMed ID: 27070304
[TBL] [Abstract][Full Text] [Related]
39. CD25 expression on cutaneous mast cells from adult patients presenting with urticaria pigmentosa is predictive of systemic mastocytosis.
Hollmann TJ; Brenn T; Hornick JL
Am J Surg Pathol; 2008 Jan; 32(1):139-45. PubMed ID: 18162781
[TBL] [Abstract][Full Text] [Related]
40. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers.
Horny HP; Sotlar K; Stellmacher F; Krokowski M; Agis H; Schwartz LB; Valent P
J Clin Pathol; 2006 Mar; 59(3):298-302. PubMed ID: 16505282
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]